City Therapeutics
A biopharmaceutical company developing RNA interference (RNAi)-based medicines.
About
Technology stack
detected 2026-06-14“Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics.”
View on Reddit“Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies.”
View on Reddit“BIIB | Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies.”
View on Reddit“It seems the tides are turning from a Biotech perspective. Three IPOs raised $900 million, and City Therapeutics and Judo Therapeutics launched.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
What does City Therapeutics do?
City Therapeutics is a biopharmaceutical company focused on advancing the field of RNA interference (RNAi)-based medicine. They are developing novel therapeutic approaches utilizing RNAi technology. (formerly [].)
How much funding has City Therapeutics raised?
City Therapeutics has raised a total of $100M in funding. The most recent round on record is Series B.
Where is City Therapeutics headquartered?
City Therapeutics is headquartered in Cambridge, Massachusetts, USA.
When was City Therapeutics founded?
City Therapeutics was founded in 2019.
What industry does City Therapeutics operate in?
City Therapeutics operates in Biotechnology, Pharmaceuticals, HealthTech, Biotech, Drug Discovery, Genomics.